Come up with a name for your new list and we'll add to it:
Argos Therapeutics raised a round of funding on February 24, 2005. Investors include
The Alliance for Lupus Research.
Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…